Ras_NN
oncogene_NN
transformation_NN
of_IN
human_JJ
B_NN
lymphoblasts_NNS
is_VBZ
associated_VBN
with_IN
lymphocyte_NN
activation_NN
and_CC
with_IN
a_DT
block_NN
of_IN
differentiation_NN
._.

The_DT
p21ras_NN
small_JJ
GTP_NN
binding_NN
proteins_NNS
participate_VBP
in_IN
signal_NN
transduction_NN
from_IN
cell_NN
surface_NN
receptors_NNS
and_CC
affect_VBP
neoplastic_JJ
transformation_NN
and_CC
development_NN
in_IN
many_JJ
different_JJ
cell_NN
types_NNS
._.

In_IN
the_DT
present_JJ
study_NN
,_,
we_PRP
examined_VBD
the_DT
relationship_NN
between_IN
ras_NN
transformation_NN
and_CC
differentiation_NN
of_IN
human_JJ
B_NN
lymphocytes_NNS
._.

We_PRP
show_VBP
that_IN
the_DT
constitutive_JJ
expression_NN
of_IN
the_DT
T24_NN
Ha-ras_NN
oncogene_NN
in_IN
EBV-immortalized_JJ
B_NN
lymphoblasts_NNS
was_VBD
associated_VBN
with_IN
the_DT
induction_NN
of_IN
the_DT
interleukin_NN
2_CD
receptor_NN
alpha_NN
subunit_NN
,_,
with_IN
an_DT
impaired_JJ
immunoglobulin_NN
gene_NN
expression_NN
,_,
altered_JJ
adhesion_NN
properties_NNS
and_CC
increased_VBN
survival_NN
in_IN
serum-free_JJ
medium_NN
._.

Since_IN
induction_NN
of_IN
the_DT
IL-2_NN
receptor_NN
alpha_NN
subunit_NN
is_VBZ
a_DT
hallmark_NN
of_IN
lymphocyte_NN
activation_NN
,_,
we_PRP
suggest_VBP
that_IN
p21ras_NN
naturally_RB
triggers_VBZ
B_NN
cell_NN
activation_NN
._.

The_DT
ras-transformed_JJ
lymphocytes_NNS
displayed_VBD
a_DT
fully_RB
functional_JJ
IL-2r_NN
,_,
as_IN
assessed_VBN
by_IN
c-fos_NN
induction_NN
following_VBG
treatment_NN
with_IN
IL-2_NN
;_:
nevertheless_RB
,_,
they_PRP
were_VBD
not_RB
growth_NN
stimulated_VBN
by_IN
this_DT
lymphokine_NN
._.

The_DT
decreased_VBN
expression_NN
of_IN
immunoglobulin_NN
genes_NNS
indicates_VBZ
that_IN
the_DT
ras_NN
oncogene_NN
blocks_VBZ
terminal_JJ
differentiation_NN
to_TO
plasma_NN
cells_NNS
,_,
possibly_RB
by_IN
inhibiting_VBG
the_DT
activity_NN
of_IN
lymphocyte-specific_JJ
transcription_NN
factors_NNS
._.

Somewhat_RB
unexpectedly_RB
,_,
the_DT
constitutive_JJ
p21ras_NN
activity_NN
did_VBD
not_RB
cause_VB
an_DT
increased_VBN
DNA_NN
binding_NN
of_IN
transcription_NN
factors_NNS
PEA1_NN
-LRB-_-LRB-
AP1_NN
-RRB-_-RRB-
,_,
PEA3_NN
,_,
Oct-2_NN
or_CC
NF-kB_NN
._.

